GyreOx Therapeutics Seed
1 known investors
Find your way into GyreOx Therapeutics Seed
Gyre Therapeutics is a biopharmaceutical company developing small-molecule therapeutics for organ fibrosis and inflammatory diseases, with its lead program F351 in clinical evaluation for liver fibrosis in the US and China. The company also operates Cullgen Inc., a subsidiary focused on targeted protein degrader therapies for cancer and inflammatory conditions.
Founders & leadership
YL
Ying Luo, Ph.D.Chief Executive Officer
YL
YX
Yue XiongChief Scientific Officer
Board
PZ
Ping ZhangChairman
Investors · 1
Frequently asked questions
- What does GyreOx Therapeutics Seed do?
- Gyre Therapeutics is a biopharmaceutical company developing small-molecule therapeutics for organ fibrosis and inflammatory diseases, with its lead program F351 in clinical evaluation for liver fibrosis in the US and China. The company also operates Cullgen Inc., a subsidiary focused on targeted protein degrader therapies for cancer and inflammatory conditions.
- Who are GyreOx Therapeutics Seed's investors?
- GyreOx Therapeutics Seed's investors include Future Planet Capital.
- Where is GyreOx Therapeutics Seed headquartered?
- GyreOx Therapeutics Seed is headquartered in Null, US.